Literature DB >> 15771043

Malignant haemangiopericytoma of the mesorectum.

Giovanni Vennarecci1, Arianna Boschetto, Alessandro Esposito, Luca Giovannelli, Francesco Buscaglia, Valerio Corazza, Roberto Santoro, Pietro Mancini, Riccardo Lorusso, Mirella Marino, Giuseppe Maria Ettorre.   

Abstract

The authors report the case of a malignant haemangiopericytoma found in an uncommon location, namely the mesorectum. Haemangiopericytomas of the mesorectum are rare mesenchymal tumours of vascular origin that usually occur in the musculature of the extremities, retroperitoneum, pelvis (uterus, ovary and urinary bladder), head, neck and lungs. Rare sites include the liver, pancreas, stomach and greater omentum. Because of their rarity the overall experience has not been significant and little has been published concerning such tumours. In addition, the difficult interpretation of the histological evidence and the poor prognosis of the disease may still give rise to problems in terms of clinical management. Haemangiopericytomas of the retrorectal space, however, seem to behave like malignant tumours: the clinical course is poor and survival short, despite radical surgery, due to early distant metastases and local recurrence. Surgery still remains the mainstay of treatment. Adjuvant therapies should be considered.

Entities:  

Mesh:

Year:  2004        PMID: 15771043

Source DB:  PubMed          Journal:  Chir Ital        ISSN: 0009-4773


  2 in total

1.  Hemangiopericytoma in the sacrococcygeal space: a case report.

Authors:  Yuji Kitahata; Shozo Yokoyama; Katsunari Takifuji; Tsukasa Hotta; Kenji Matsuda; Toshiji Tominaga; Yoshimasa Oku; Takashi Watanabe; Junji Ieda; Hiroki Yamaue
Journal:  J Med Case Rep       Date:  2010-01-14

2.  Large hemangiopericytoma of the pelvis--towards a multidisciplinary approach.

Authors:  Mohammad Fard-Aghaie; Gregor A Stavrou; Human Honarpisheh; Klaus J Niehaus; Karl J Oldhafer
Journal:  World J Surg Oncol       Date:  2015-08-28       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.